510 related articles for article (PubMed ID: 10445808)
21. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
22. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
23. CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
Benito JM; López M; Lozano S; Martinez P; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):227-33. PubMed ID: 15018711
[TBL] [Abstract][Full Text] [Related]
24. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
[TBL] [Abstract][Full Text] [Related]
25. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
[TBL] [Abstract][Full Text] [Related]
26. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
Lieberman J; Trimble LA; Friedman RS; Lisziewicz J; Lori F; Shankar P; Jessen H
AIDS; 1999 May; 13(8):891-9. PubMed ID: 10371169
[TBL] [Abstract][Full Text] [Related]
27. Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations.
Jiang JQ; Balasubramanian S; Hawley-Foss NC; Badley AD; Rosenthal KL; Copeland KF
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):497-502. PubMed ID: 12882659
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
Hultin LE; Matud JL; Giorgi JV
Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
[TBL] [Abstract][Full Text] [Related]
29. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
[TBL] [Abstract][Full Text] [Related]
30. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
32. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
[TBL] [Abstract][Full Text] [Related]
33. Adrenaline-induced mobilization of T cells in HIV-infected patients.
Søndergaard SR; Cozzi Lepri A; Ullum H; Wiis J; Hermann CK; Laursen SB; Qvist J; Gerstoft J; Skinhøj P; Pedersen BK
Clin Exp Immunol; 2000 Jan; 119(1):115-22. PubMed ID: 10606972
[TBL] [Abstract][Full Text] [Related]
34. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O; Holub M; Spála J; Kalanin J; Stanková M
Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
[TBL] [Abstract][Full Text] [Related]
35. Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.
Wu H; Kuritzkes DR; McClernon DR; Kessler H; Connick E; Landay A; Spear G; Heath-Chiozzi M; Rousseau F; Fox L; Spritzler J; Leonard JM; Lederman MM
J Infect Dis; 1999 Apr; 179(4):799-807. PubMed ID: 10068574
[TBL] [Abstract][Full Text] [Related]
36. Nucleoside-free boosted double PI regimen: significant CD4+ T-cell recovery in patients with poor immunologic response despite virologic suppression.
Lehmann C; Jung N; Hofmann A; Cornely OA; Wyen C; Fätkenheuer G; Hartmann P
Curr HIV Res; 2008 Nov; 6(6):555-9. PubMed ID: 18991621
[TBL] [Abstract][Full Text] [Related]
37. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
[TBL] [Abstract][Full Text] [Related]
38. Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
Nokta M; Rossero R; Nichols J; Rosenbaum M; Pollard RB
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):255-64. PubMed ID: 10052756
[TBL] [Abstract][Full Text] [Related]
39. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
[TBL] [Abstract][Full Text] [Related]
40. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]